248 related articles for article (PubMed ID: 28864644)
21. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H
Respir Med; 2020; 165():105920. PubMed ID: 32174452
[TBL] [Abstract][Full Text] [Related]
22. [Predictive factors and unfavorable prognostic factorial analysis of interstitial lung disease in patients with inflammatory myopathy].
Li R; Li XP; Li XM; Wang GS; Qian L; Tao JH; Ma Y; Zhang H
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2335-8. PubMed ID: 23158563
[TBL] [Abstract][Full Text] [Related]
23. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.
Sugiyama Y; Yoshimi R; Tamura M; Takeno M; Kunishita Y; Kishimoto D; Yoshioka Y; Kobayashi K; Takase-Minegishi K; Watanabe T; Hamada N; Nagai H; Tsuchida N; Soejima Y; Nakano H; Kamiyama R; Uehara T; Kirino Y; Sekiguchi A; Ihata A; Ohno S; Nagaoka S; Nakajima H
Arthritis Res Ther; 2018 Jan; 20(1):7. PubMed ID: 29325580
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
[TBL] [Abstract][Full Text] [Related]
25. Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies.
Misra AK; Wong NL; Healey TT; Lally EV; Shea BS
BMC Pulm Med; 2021 Nov; 21(1):370. PubMed ID: 34775966
[TBL] [Abstract][Full Text] [Related]
26. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology.
Fathi M; Vikgren J; Boijsen M; Tylen U; Jorfeldt L; Tornling G; Lundberg IE
Arthritis Rheum; 2008 May; 59(5):677-85. PubMed ID: 18438901
[TBL] [Abstract][Full Text] [Related]
27. Interstitial lung disease related to rheumatoid arthritis: evolution after treatment.
Rojas-Serrano J; González-Velásquez E; Mejía M; Sánchez-Rodríguez A; Carrillo G
Reumatol Clin; 2012; 8(2):68-71. PubMed ID: 22341526
[TBL] [Abstract][Full Text] [Related]
28. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
Yoshifuji H; Fujii T; Kobayashi S; Imura Y; Fujita Y; Kawabata D; Usui T; Tanaka M; Nagai S; Umehara H; Mimori T
Autoimmunity; 2006 May; 39(3):233-41. PubMed ID: 16769657
[TBL] [Abstract][Full Text] [Related]
29. Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.
Koyama RVL; Braga TKK; da Silva Dias GA; Fujihara S; Fuzii HT; Yoshikawa GT
Clin Rheumatol; 2017 Aug; 36(8):1919-1926. PubMed ID: 28488124
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
[TBL] [Abstract][Full Text] [Related]
31. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.
Andersson H; Sem M; Lund MB; Aaløkken TM; Günther A; Walle-Hansen R; Garen T; Molberg Ø
Rheumatology (Oxford); 2015 Aug; 54(8):1420-8. PubMed ID: 25740830
[TBL] [Abstract][Full Text] [Related]
32. Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis.
Barba T; Fort R; Cottin V; Provencher S; Durieu I; Jardel S; Hot A; Reynaud Q; Lega JC
Autoimmun Rev; 2019 Feb; 18(2):113-122. PubMed ID: 30572131
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary manifestations of polymyositis/dermatomyositis.
Hallowell RW; Ascherman DP; Danoff SK
Semin Respir Crit Care Med; 2014 Apr; 35(2):239-48. PubMed ID: 24668538
[TBL] [Abstract][Full Text] [Related]
34. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB
Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic advances in myositis.
Aggarwal R; Oddis CV
Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
[TBL] [Abstract][Full Text] [Related]
36. Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease.
Huapaya JA; Hallowell R; Silhan L; Pinal-Fernandez I; Casal-Dominguez M; Johnson C; Albayda J; Paik JJ; Lin CT; Hussien A; Mammen AL; Christopher-Stine L; Danoff SK
Respir Med; 2019; 154():6-11. PubMed ID: 31176796
[TBL] [Abstract][Full Text] [Related]
37. Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature.
Ingegnoli F; Lubatti C; Ingegnoli A; Boracchi P; Zeni S; Meroni PL
Autoimmun Rev; 2012 Mar; 11(5):335-40. PubMed ID: 21985773
[TBL] [Abstract][Full Text] [Related]
38. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
Hozumi H; Fujisawa T; Enomoto N; Nakashima R; Enomoto Y; Suzuki Y; Kono M; Karayama M; Furuhashi K; Murakami A; Inui N; Nakamura Y; Mimori T; Suda T
J Rheumatol; 2017 Sep; 44(9):1394-1401. PubMed ID: 28711881
[TBL] [Abstract][Full Text] [Related]
39. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
[TBL] [Abstract][Full Text] [Related]
40. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
